Form 8-K - Current report:
SEC Accession No. 0001213900-24-107906
Filing Date
2024-12-11
Accepted
2024-12-11 16:19:23
Documents
22
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0224389-8k_protara.htm   iXBRL 8-K 51441
2 UNDERWRITING AGREEMENT, DATED DECEMBER 9, 2024, BY AND AMONG THE COMPANY, TD SEC ea022438901ex1-1_protara.htm EX-1.1 240989
3 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT ea022438901ex4-1_protara.htm EX-4.1 85206
4 OPINION OF SULLIVAN & CROMWELL LLP ea022438901ex5-1_protara.htm EX-5.1 6658
5 PRESS RELEASE, DATED DECEMBER 9, 2024 ea022438901ex99-1_protara.htm EX-99.1 8014
6 PRESS RELEASE, DATED DECEMBER 9, 2024 ea022438901ex99-2_protara.htm EX-99.2 7978
7 PRESS RELEASE, DATED DECEMBER 11, 2024 ea022438901ex99-3_protara.htm EX-99.3 7733
8 GRAPHIC ex99-1_001.jpg GRAPHIC 7452
9 GRAPHIC ex99-2_001.jpg GRAPHIC 2363
10 GRAPHIC ex99-3_001.jpg GRAPHIC 2415
  Complete submission text file 0001213900-24-107906.txt   700416

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE tara-20241209.xsd EX-101.SCH 3018
12 XBRL LABEL FILE tara-20241209_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE tara-20241209_pre.xml EX-101.PRE 22361
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0224389-8k_protara_htm.xml XML 3749
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 241541766
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)